Somatostatin receptor mediated targeting of acute myeloid leukemia by photodynamic metal complexes for light induced apoptosis

Acute myeloid leukemia (AML) is characterized by relapse and treatment resistance in a major fraction of patients, underlining the need of innovative AML targeting therapies. Here we analysed the therapeutic potential of an innovative biohybrid consisting of the tumor-associated peptide somatostatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vegi, Naidu M., Chakrabortty, Sabyasachi, Zegota, Maksymilian M., Kuan, Seah Ling, Stumper, Anne, Rawat, Vijay P. S., Sieste, Stefanie, Buske, Christian, Rau, Sven, Weil, Tanja, Feuring-Buske, Michaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962389/
https://www.ncbi.nlm.nih.gov/pubmed/31941913
http://dx.doi.org/10.1038/s41598-019-57172-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962389/
https://www.ncbi.nlm.nih.gov/pubmed/31941913
http://dx.doi.org/10.1038/s41598-019-57172-6

Ejemplares similares